ASTRAZEN — Astrazeneca Pharma India Share News
0.000.00%
Last trade - 00:00- IN₹210.84bn
- IN₹207.37bn
- IN₹22.76bn
Brief: Astrazeneca Pharma India Dividend Of 32 Rupees Per Share
Brief: Astrazeneca Pharma India Receives Permission To Import Osimertinib Tablets
Brief: Astrazeneca Pharma India Receives Approval For Enhertu In India
Brief: Astrazeneca Pharma India Surrenders Marketing Authorisation For Olaparib Tablets
Brief: Astrazeneca Pharma India To Discontinue Manufacturing, Marketing Of Prolonged Release Isosorbide-5-Mononitrate Tablets BP
AstraZeneca Pharma India gains on regulator nod to import lung cancer drug
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab Solution
Brief: Astrazeneca Pharma India Receives Permission To Import Pharmaceutical Formulations Of Lokelma
India's AstraZeneca Pharma up on import nod for liver cancer drug
Brief: Astrazeneca Pharma India Receives Permission To Import Durvalumab For Additional Indication
India's Astrazeneca Pharma gains on quarterly profit jump
Brief: Astrazeneca Pharma India Dec-Quarter PAT 308.5 Mln Rupees
Astrazeneca results, rate cut bets power FTSE 100 to record close (updated)
Newscasts - AstraZeneca shares rise as China probe update reassures
AstraZeneca CEO: UK must improve investment environment
Live Markets: Japan: small (and medium) is beautiful
Global Markets: European shares climb to record high ahead of BoE rate cut
STOXX 600 hits record high on robust earnings; all eyes on BoE rate decision (updated)
AstraZeneca CEO says company has no access to executive Wang, in detention in China